Elimination of infused branched-chain amino-acids from plasma of patients with non-obese type 2 diabetes mellitus
1991; Elsevier BV; Volume: 10; Issue: 2 Linguagem: Inglês
10.1016/0261-5614(91)90096-u
ISSN1532-1983
AutoresGiulio Marchesini, Giampaolo Bianchi, Hendrik Vilstrup, Giovanni Capelli, Marco Zoli, E Pisi,
Tópico(s)Adipose Tissue and Metabolism
ResumoIncreased plasma levels of branched-chain amino-acids (BCAA) have been demonstrated in poorly controlled diabetes mellitus, and related to absolute or relative insulin deficiency. To study the pathogenesis of this alteration, the elimination of BCAA from plasma was measured in 8 patients with non-obese type 2 diabetes mellitus and in 8 age-matched control subjects during steady-state BCAA concentrations induced by a primed-continuous infusion. Fasting BCAA levels were increased by 40–50% in patients with diabetes. The plasma clearances of valine, isoleucine, and leucine, calculated as infusion rate divided by steady-state concentration, were reduced by 20% in diabetics, despite 50% hyperinsulinemia (P < 0.01). Basal BCAA levels and BCAA clearance were negatively correlated (r2 = 0.46 − 0.56). The endogenous basal appearance rates of BCAA, estimated by the basal concentrations multiplied by the plasma clearances, were normal in diabetics, and there was no difference in the apparent volumes of distribution of BCAA. The increased basal concentration of BCAA in poorly controlled type 2 diabetics (693 [SD 114; n = 8] μmol/l vs 479 [88; n = 8] in controls (P < 0.005) is attributable to changes in plasma clearances, without any change in the efflux of BCAA into plasma. This may be due to insulin resistance.
Referência(s)